• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高发展指数和高卫生支出国家肝癌死亡率与发病率比值的改善趋势。

Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures.

作者信息

Su Chang-Cheng, Chen Brian-Shiian, Chen Hsin-Hung, Sung Wen-Wei, Wang Chi-Chih, Tsai Ming-Chang

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.

出版信息

Healthcare (Basel). 2023 Jan 4;11(2):159. doi: 10.3390/healthcare11020159.

DOI:10.3390/healthcare11020159
PMID:36673528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9859532/
Abstract

Primary liver cancer is one of the leading causes of death globally. Liver cancer has a unique geographical distribution, as its etiologies include chronic viral infections and aging. We hypothesize that the human development index (HDI), current health expenditure (CHE) per capita, and CHE-to-gross domestic product ratio (CHE/GDP) influence the incidence, mortality, and mortality-to-incidence ratios (MIRs) of liver cancer worldwide. Data were obtained from the Global Cancer Observatory (GLOBOCAN) database and the World Health Organization. MIRs and the changes in MIR over time (δMIR) were used to evaluate the correlation of expenditures on healthcare and the HDI disparities via Spearman's rank correlation coefficient. The crude incidence and mortality were significantly associated with HDI, CHE per capita, and CHE/GDP. Specifically, there were significant associations between δMIR and HDI, as well as between δMIR and CHE per capita. However, there were no significant associations between δMIR and CHE/GDP. Evidently, a favorable liver cancer δMIR was not associated with CHE/GDP, although it had a significant association with HDI and CHE per capita. These results are worthy of the attention of public health systems in correlation to improved outcomes in liver cancer.

摘要

原发性肝癌是全球主要死因之一。肝癌具有独特的地理分布,因为其病因包括慢性病毒感染和老龄化。我们假设人类发展指数(HDI)、人均当前卫生支出(CHE)以及卫生支出与国内生产总值的比率(CHE/GDP)会影响全球肝癌的发病率、死亡率以及死亡率与发病率之比(MIR)。数据来自全球癌症观测站(GLOBOCAN)数据库和世界卫生组织。通过斯皮尔曼等级相关系数,使用MIR以及MIR随时间的变化(δMIR)来评估医疗保健支出与HDI差异之间的相关性。粗发病率和死亡率与HDI、人均CHE以及CHE/GDP显著相关。具体而言,δMIR与HDI之间以及δMIR与人均CHE之间存在显著关联。然而,δMIR与CHE/GDP之间没有显著关联。显然,尽管肝癌的δMIR与HDI和人均CHE存在显著关联,但它与CHE/GDP无关。这些结果值得公共卫生系统关注,以改善肝癌治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/fb86a9096785/healthcare-11-00159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/1ea90783a030/healthcare-11-00159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/8f81c0f60f22/healthcare-11-00159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/fb86a9096785/healthcare-11-00159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/1ea90783a030/healthcare-11-00159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/8f81c0f60f22/healthcare-11-00159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/678f/9859532/fb86a9096785/healthcare-11-00159-g003.jpg

相似文献

1
Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures.高发展指数和高卫生支出国家肝癌死亡率与发病率比值的改善趋势。
Healthcare (Basel). 2023 Jan 4;11(2):159. doi: 10.3390/healthcare11020159.
2
Gender differences in trends of bladder cancer mortality-to-incidence ratios according to health expenditure in 55 countries.55个国家中膀胱癌死亡率与发病率之比趋势的性别差异与卫生支出的关系
PLoS One. 2021 Feb 12;16(2):e0244510. doi: 10.1371/journal.pone.0244510. eCollection 2021.
3
Improved trends of lung cancer mortality-to-incidence ratios in countries with high healthcare expenditure.高医疗支出国家的肺癌死亡率与发病率比值呈改善趋势。
Thorac Cancer. 2021 Jun;12(11):1656-1661. doi: 10.1111/1759-7714.13912. Epub 2021 Apr 7.
4
Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020.基于2020年全球癌症负担估计数据,白血病治疗结果中的性别差异与医疗保健支出的关系。
Arch Public Health. 2023 Aug 21;81(1):151. doi: 10.1186/s13690-023-01154-8.
5
Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health.高人类发展指数和卫生支出国家的唇癌和口腔癌死亡率与发病率比值有利。
Int J Environ Res Public Health. 2021 Jun 3;18(11):6012. doi: 10.3390/ijerph18116012.
6
Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries.56 个国家的医疗支出与肾癌死亡率与发病率比值的变化趋势。
Sci Rep. 2021 Jan 14;11(1):1479. doi: 10.1038/s41598-020-79367-y.
7
Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures.高卫生支出发达国家胃癌病死率与发病率比值的改善。
Front Public Health. 2021 Aug 17;9:713895. doi: 10.3389/fpubh.2021.713895. eCollection 2021.
8
Favorable breast cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.在人类发展指数排名较高和卫生支出较高的国家,乳腺癌死亡率与发病率的比值有利。
Taiwan J Obstet Gynecol. 2024 Jul;63(4):527-531. doi: 10.1016/j.tjog.2023.11.012.
9
Favorable colorectal cancer mortality-to-incidence ratios in countries with high expenditures on health and development index: A study based on GLOBOCAN database.高卫生支出和高发展指数国家的结直肠癌死亡率与发病率比值有利:基于 GLOBOCAN 数据库的研究。
Medicine (Baltimore). 2021 Oct 15;100(41):e27414. doi: 10.1097/MD.0000000000027414.
10
Trends of Testicular Cancer Mortality-to-Incidence Ratios in Relation to Health Expenditure: An Ecological Study of 54 Countries.睾丸癌死亡率与发病率比值与卫生支出关系的趋势:54 个国家的生态学研究。
Int J Environ Res Public Health. 2021 Feb 6;18(4):1546. doi: 10.3390/ijerph18041546.

引用本文的文献

1
The relationship between public health expenditure and urban economic resilience.公共卫生支出与城市经济韧性之间的关系。
Front Public Health. 2025 Feb 14;13:1550528. doi: 10.3389/fpubh.2025.1550528. eCollection 2025.
2
Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata.中东和北非(MENA)地区儿童及青少年癌症差异:不同社会经济阶层的发病率、死亡率和生存率
BMC Public Health. 2024 Dec 30;24(1):3602. doi: 10.1186/s12889-024-21155-8.
3
An Analysis of Radiotherapy Machine Requirements in India: Impact of the Pandemic and Regional Disparities.

本文引用的文献

1
Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019.全球疾病负担 1990-2019 年肝癌病因全球、区域和国家负担及护理质量指数趋势。
Hepatol Commun. 2022 Jul;6(7):1764-1775. doi: 10.1002/hep4.1910. Epub 2022 Feb 8.
2
Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.2017 年乌克兰儿童乙型肝炎病毒感染标志物血清流行率。
Vaccine. 2021 Mar 5;39(10):1485-1492. doi: 10.1016/j.vaccine.2021.02.004. Epub 2021 Feb 12.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
印度放射治疗设备需求分析:疫情影响与地区差异
J Med Phys. 2024 Jul-Sep;49(3):370-378. doi: 10.4103/jmp.jmp_20_24. Epub 2024 Sep 21.
4
Epidemiology and socioeconomic correlates of brain and central nervous system cancers in Asia in 2020 and their projection to 2040.2020 年亚洲脑和中枢神经系统癌症的流行病学和社会经济学相关性及其到 2040 年的预测。
Sci Rep. 2024 Sep 20;14(1):21936. doi: 10.1038/s41598-024-73277-z.
5
Analyzing Global Cancer Control: Progress of National Cancer Control Programs through Composite Indicators and Regression Modeling.分析全球癌症控制:通过综合指标和回归模型评估国家癌症控制项目的进展
J Med Phys. 2024 Apr-Jun;49(2):225-231. doi: 10.4103/jmp.jmp_21_24. Epub 2024 Jun 25.
6
Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌中的疾病修饰因子和新型标志物
J Liver Cancer. 2024 Sep;24(2):145-154. doi: 10.17998/jlc.2024.08.03. Epub 2024 Aug 5.
7
Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators.参与国际未确诊疾病网络的国家中未满足的需求:一项考虑国家医疗保健和经济指标的国际调查。
Front Public Health. 2023 Sep 26;11:1248260. doi: 10.3389/fpubh.2023.1248260. eCollection 2023.
8
Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020.高人类发展指数和高医疗支出国家中更好的乳腺癌护理模式:来自 GLOBOCAN 2020 的洞察。
Front Public Health. 2023 Apr 12;11:1137286. doi: 10.3389/fpubh.2023.1137286. eCollection 2023.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Hepatocellular carcinoma: old friends and new tricks.肝细胞癌:旧友与新招。
Exp Mol Med. 2020 Dec;52(12):1898-1907. doi: 10.1038/s12276-020-00527-1. Epub 2020 Dec 2.
5
Limited improvement in prostate cancer mortality-to-incidence ratios in countries with high health care expenditures.在医疗保健支出较高的国家,前列腺癌死亡率与发病率比值的改善有限。
Aging (Albany NY). 2020 Nov 12;12(21):21308-21315. doi: 10.18632/aging.103865.
6
International trends in hepatocellular carcinoma incidence, 1978-2012.国际 1978-2012 年肝细胞癌发病率趋势。
Int J Cancer. 2020 Jul 15;147(2):317-330. doi: 10.1002/ijc.32723. Epub 2019 Nov 5.
7
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.肝内和肝外胆管癌的危险因素:系统评价和荟萃分析。
J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16.
8
Impact of national Human Development Index on liver cancer outcomes: Transition from 2008 to 2018.国家人类发展指数对肝癌结局的影响:2008 年至 2018 年的转变。
World J Gastroenterol. 2019 Aug 28;25(32):4749-4763. doi: 10.3748/wjg.v25.i32.4749.
9
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
10
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.